Discover how ADDYI increased sexual desire and decreased associated distress in premenopausal women with acquired, generalized HSDD. See full safety info.

IMVEXXY® (estradiol vaginal insert) is an FDA approved treatment for women with moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. Please see Important Safety Information.

INTRAROSA® (prasterone) is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.

PREMARIN VAGINAL CREAM should not be used in women with any of the following conditions: undiagnosed abnormal genital bleeding; known, suspected, ...

Dec 5th, 2019 - IMVEXXY is an estrogen indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. (1)

Nov 10th, 2019 - PREMARIN (conjugated estrogens) Vaginal Cream is a mixture of estrogens indicated for: Treatment of Atrophic Vaginitis and Kraurosis Vulvae (1.1) Treatment of Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy, due to Menopause (1.2)

Oct 16th, 2019 - INTRAROSA® is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. INTRAROSA® is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. (1)

Jan 2nd, 2019 - For temporary relief of symptoms related to aging including deterioration of muscles, joints, and skin, sexual dysfunction, memory loss and fatigue.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Dec 20th, 2018 - ESTRING (estradiol vaginal ring) is an estrogen indicated for the treatment of moderate to severe urogenital symptoms due to postmenopausal atrophy of the vagina (such as dryness, burning, pruritus and dyspareunia) and/or the lower urinary tract (urinary urgency and dysuria).

Dec 5th, 2018 - For the temporary relief of symptoms related to blood pressure, such as headache, fatigue, confusion, and sexual dysfunction.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Nov 5th, 2018 - For temporary relief of symptoms related to aging including deterioration of muscles, joints and skin, sexual dysfunction, memory loss and fatigue.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Oct 31st, 2018 - OSPHENA is indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. OSPHENA is an estrogen agonist/antagonist indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause (1)

Sep 30th, 2018 - INDICATIONS: For the temporary relief from symptoms including anxiety, complusive destructive behavior, appetite control, depression, hypertension, hives, erectile disorder, lethargy, poor memory, slow metabolism, mood swings, travel sickness.

Dec 19th, 2017 - For the temporary relief of male sexual dysfunction and low back pain.